Non-coding hexanucleotide (GGGGCC) repeat expansions in *C9ORF72* are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD; C9ALS/FTD). Decreased C9orf72 protein levels in C9ALS/FTD patients \[[@CR4]\] support the idea that C9ORF72 haploinsufficiency may contribute to disease pathogenesis. To test this hypothesis, we previously generated and analyzed neural-specific *C9orf72* knockout mice. Our results showed that neural-specific ablation of C9orf72 (3110043O21Rik) in mice does not cause motor neuron degeneration or changes in motor function \[[@CR3]\]. We therefore concluded that loss of C9ORF72 on its own is unlikely to cause ALS and that reducing C9ORF72 levels may comprise a promising strategy to treat C9-ALS patients. This therapeutic potential led us, and others \[[@CR1], [@CR2]\], to subsequently analyze knockout mice lacking C9orf72 in all tissues. Importantly, in contrast to our previous report, we find that full ablation of C9orf72 induces reduced survival (Fig. [1](#Fig1){ref-type="fig"}a), which is in line with a recent study by Atanasio et al. \[[@CR1]\] who report, but do not specify, decreased survival rates. In line with our previous observations \[[@CR3]\], full C9orf72 ablation results in a 5.9 % decrease in body weight (*P* = 0.0056), without affecting motor function (accelerating rotarod and grip strength test) or inducing pathological hallmarks of ALS (see also \[[@CR1], [@CR2]\]), such as motor neuron degeneration, gliosis, enhanced ubiquitination and TDP-43 mislocalization. However, post-mortem analysis of full *C9orf72* knockout mice (*n* = 5; 11--15 months of age) revealed enlarged lymph nodes (LNs) (*n* = 4 mice) and splenomegaly (*n* = 5) (Fig. [1](#Fig1){ref-type="fig"}b). Detailed histological evaluation detected massive infiltration of histiocytes/macrophages and lymphocytes in multiple organs, including LNs, spleen, bone marrow, liver, kidney and lung (Fig. [1](#Fig1){ref-type="fig"}c--k). In addition to these immunological phenotypes, which are in part also reported by Atanasio et al. \[[@CR1]\] and O'Rourke et al. \[[@CR2]\], we detect evidence of neoplastic events. LNs of several animals (*n* = 4) contained infiltrates of B220/CD45R-positive B-lymphocytes that disrupted tissue architecture and were accompanied by increased expression of the proliferation marker Ki67, suggesting the development of B-cell lymphomas (Fig. [1](#Fig1){ref-type="fig"}c--e). Furthermore, disrupted tissue architecture and homogeneous populations of F4/80-positive macrophages expressing Ki67 were present in LNs (*n* = 3), spleen (*n* = 3), liver (*n* = 1) and lung (*n* = 1). Moreover, infiltrating cells in the liver and lung accumulated in intravascular spaces (Fig. [1](#Fig1){ref-type="fig"}f--k), suggesting the occurrence of metastatic histiocytic sarcomas. These results indicate that the defects in immune cell function recently reported in *C9orf72* knockout mice (e.g. changes in endosome/lysosomal trafficking, cytokine production) \[[@CR1], [@CR2]\] may ultimately lead to neoplastic events in multiple organs. These findings have important implications as they indicate that strategies aimed at lowering systemic C9ORF72 levels in C9ALS/FTD patients may have negative side effects and that emphasis should be on therapeutic approaches that selectively target the hexanucleotide repeat expansions or their downstream pathogenic effects.Fig. 1*C9orf72* knockout mice display reduced survival, immune system-related pathology and neoplastic events. **a** Kaplan--Meier curves show survival rates corrected for gender and body weight. *C9orf72* knockout mice show reduced survival as compared to littermate controls (Hazard ratio = 19.0; 95 %, CI: 2.4--150.2, *P* = 0.005). Wild-type controls *n* = 24; *C9orf72* knockout *n* = 29. **b** Gross image showing enlarged lymph nodes (LNs; *black arrows*) and splenomegaly (*white arrow*) in a *C9orf72* knockout mouse (12 months of age). **c**--**e** B-cell lymphoma in the submandibular LNs of *C9orf72* knockout mouse. Nodal tissue is effaced by a monotypic cell population composed of B220/CD45R-positive lymphocytes (B cells). Note the high proliferation rate of the neoplastic lymphocytes as indicated by immunostaining for Ki67 (proliferation marker). **f**--**h** Histiocytic sarcoma in the liver of *C9orf72* knockout mouse. Hepatic sinusoids are filled with atypical histiocytes and multinucleated giant cells that stain positive for the macrophage lineage marker F4/80 and exhibit a high proliferation rate, as evidenced by Ki67 immunostaining. **i**--**k** Histiocytic sarcoma in lung vasculature in *C9orf72* knockout mouse. Pulmonary blood vessels are filled with atypical and multinucleated giant cells that immunostain for F4/80 and Ki67. *H&E* hematoxylin and eosin. *Scale bar* 1.3 cm (**b**), 65 μm (**c**), 40 μm (**d**--**h**), 125 μm (**i**), and 90 μm (**j**, **k**)
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